JTCS Speed Up Your Browser
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, D. B.
Right arrow Articles by Ivey, T. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, D. B.
Right arrow Articles by Ivey, T. D.

The Journal of Thoracic and Cardiovascular Surgery, Vol 90, 592-596, Copyright © 1985 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Oral verapamil for prophylaxis of supraventricular tachycardia after myocardial revascularization. A randomized trial

DB Williams, GA Misbach, AP Kruse and TD Ivey

To determine if the prophylactic administration of oral verapamil is effective in reducing the incidence of supraventricular tachycardia after myocardial revascularization, 141 patients were entered into a double-blind randomized trial. Seventy patients received verapamil 80 mg every 8 hours beginning immediately after operation and continuing for 5 days, and 71 patients received placebo. Patients were monitored during the study period and observed for the occurrence of supraventricular tachycardia. The verapamil and placebo groups were similar with regard to sex, age, preoperative antianginal drugs, number of bypass grafts, average bypass time, and average occlusion time. A total of 39 patients had supraventricular tachycardia, 20 were receiving verapamil, and 19 were receiving placebo. The average ventricular rate was 127 +/- 13 beats/min for the verapamil group with supraventricular tachycardia compared with 140 +/- 12 beats/min for the placebo group with the mean differences not significant (p = 0.10). On the basis of these data, it is concluded that verapamil 80 mg every 8 hours beginning early after myocardial revascularization is not effective in reducing the incidence of supraventricular tachycardia.


This article has been cited by other articles:


Home page
ChestHome page
D. Bradley, L. L. Creswell, C. W. Hogue Jr., A. E. Epstein, E. N. Prystowsky, and E. G. Daoud
Pharmacologic Prophylaxis: American College of Chest Physicians Guidelines for the Prevention and Management of Postoperative Atrial Fibrillation After Cardiac Surgery
Chest, August 1, 2005; 128(2_suppl): 39S - 47S.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Yagdi, S. Nalbantgil, F. Ayik, A. Apaydin, F. Islamoglu, H. Posacioglu, T. Calkavur, Y. Atay, and S. Buket
Amiodarone reduces the incidence of atrial fibrillation after coronary artery bypass grafting
J. Thorac. Cardiovasc. Surg., June 1, 2003; 125(6): 1420 - 1425.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. N. Wijeysundera, W. S. Beattie, V. Rao, and J. Karski
Calcium antagonists reduce cardiovascular complications after cardiac surgery: A meta-analysis
J. Am. Coll. Cardiol., May 7, 2003; 41(9): 1496 - 1505.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
H. Tokmakoglu, O. Kandemir, S. Gunaydin, Z. Catav, C. Yorgancioglu, and Y. Zorlutuna
Amiodarone versus digoxin and metoprolol combination for the prevention of postcoronary bypass atrial fibrillation
Eur. J. Cardiothorac. Surg., March 1, 2002; 21(3): 401 - 405.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
W. H. Maisel, J. D. Rawn, and W. G. Stevenson
Atrial Fibrillation after Cardiac Surgery
Ann Intern Med, December 18, 2001; 135(12): 1061 - 1073.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
H. Dorge, F. A. Schoendube, M. Schoberer, C. Stellbrink, M. Voss, and B. J. Messmer
Intraoperative amiodarone as prophylaxis against atrial fibrillation after coronary operations
Ann. Thorac. Surg., May 1, 2000; 69(5): 1358 - 1362.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. A. Eagle, R. A. Guyton, R. Davidoff, G. A. Ewy, J. Fonger, T. J. Gardner, J. P. Gott, H. C. Herrmann, R. A. Marlow, W. C. Nugent, et al.
ACC/AHA guidelines for coronary artery bypass graft surgery: A report of the American College of Cardiology/ American Heart Association task force on Practice Guidelines (Committee to revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery)
J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1262 - 1347.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. E. Pfisterer, U. C. D. Kloter-Weber, M. Huber, S. Osswald, P. T. Buser, K. Skarvan, and P. M. Stulz
Prevention of Supraventricular Tachyarrhythmias After Open Heart Operation by Low-Dose Sotalol: A Prospective, Double-Blind, Randomized, Placebo-Controlled Study
Ann. Thorac. Surg., October 1, 1997; 64(4): 1113 - 1119.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
W. Van Mieghem, G. Tits, K. Demuynck, L. Lacquet, G. Deneffe, T. Tjandra-Maga, and M. Demedts
Verapamil as Prophylactic Treatment for Atrial Fibrillation After Lung Operations
Ann. Thorac. Surg., April 1, 1996; 61(4): 1083 - 1085.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1985 by The American Association for Thoracic Surgery.